Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:e430-e431
doi: 10.1161/CIRCULATIONAHA.106.674911
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shiozaki, A. A.
Right arrow Articles by Rochitte, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shiozaki, A. A.
Right arrow Articles by Rochitte, C. E.
Related Collections
Right arrow Hypertrophy
Right arrow Myocardial cardiomyopathy disease
Right arrow CT and MRI

(Circulation. 2007;115:e430-e431.)
© 2007 American Heart Association, Inc.


Images in Cardiovascular Medicine

Myocardial Delayed Enhancement by Computed Tomography in Hypertrophic Cardiomyopathy

Afonso Akio Shiozaki, MD; Tiago Senra Garcia Santos, MD; Edmundo Artega, MD, PhD; Carlos Eduardo Rochitte, MD, PhD

From the Cardiovascular Magnetic Resonance and Computed Tomography Sector of Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil.

Correspondence to Carlos E. Rochitte, MD, PhD, Instituto do Coração, InCor, Setor de Ressonância Magnética e Tomografia Computadorizada Cardiovascular, Av. Dr. Enéas de Carvalho Aguiar, 44, Cerqueira César, São Paulo, SP Brazil 05403–000. E-mail rochitte{at}incor.usp.br

A 35-year-old woman with a previous diagnosis of hypertrophic cardiomyopathy (HCM) was admitted to the Heart Institute of the University of São Paulo Medical School for recurrent palpitation and syncope. The patient had 2 brothers who already had been diagnosed with HCM, and her mother had died suddenly at the age of 38.

ECG revealed sinus-rhythm and left–bundle branch block. A tilt-table test was negative, and 24-hour Holter monitoring showed one isolated episode of nonsustained ventricular tachycardia with 3 beatings.

Echocardiography revealed hypertrophy of the septal (24 mm) and inferior walls (Movie I), with a maximum systolic gradient of 77 mm Hg. Left ventricular ejection fraction was estimated at 72%, and mass index was estimated at 268 g/m.2

Left ventricular hypertrophy was confirmed by cardiovascular magnetic resonance (CMR) and a 30-mm septum thickness was noted (Figure, A and D, and Movie II). Left ventricular ejection fraction was calculated (Simpson) at 77%, and mass index was calculated at 164 g/m2. Delayed enhancement by CMR demonstrated multiple foci of myocardial fibrosis, particularly in the septum and in its junctions with the right ventricular free wall, which has been correlated with the prevalence of risk factors for sudden death1 in HCM patients.


Figure 1183191
View larger version (110K):
[in this window]
[in a new window]

 
CMR and multidetector computed tomography in a patient with hypertrophic cardiomyopathy. A and D, Steady-state free precession (SSFP) with asymmetrical septal and inferior hypertrophy in 2-chamber long-axis (A) and short-axis (D) views by CMR. B and E, Multiple foci of delayed enhancement (myocardial fibrosis) by CMR (arrows), identically reproduced in location and geometry by delayed-enhancement multidetector computed tomography (arrows, C and F).

The patient was then submitted to cardiac multidetector computed tomography (Aquilion 64, Toshiba Inc., Japan) 10 minutes after injection of 150 mL of iodine contrast (Iopamiron 370, Shering AG, Germany). Images by multidetector computed tomography showed multiple areas of delayed enhancement in the septum that precisely matched the CMR delayed-enhancement findings (Figure, B, C, E, and F).

On the basis of the overall risk factors and test results, the patient received an implantable cardioverter–defibrillator.

Recently, myocardial fibrosis has been identified in ischemic patients by multidetector computed tomography, demonstrating infarcted areas similarly to CMR.2,3

To our knowledge, this is the first demonstration of myocardial fibrosis by multidetector computed tomography in HCM patients. Such findings may be useful in the evaluation of HCM patients with contraindications for CMR (eg, pacemakers, implantable cardioverter–defibrillators, and claustrophobia).


*    Disclosures
up arrowTop
*Disclosures
down arrowReferences
 
None.


*    Footnotes
 
The online-only Data Supplement, consisting of Movies I and II, is available with this article at http://circ.ahajournals.org/cgi/content/full/115/17/e430/DC1.


*    References
up arrowTop
up arrowDisclosures
*References
 
1. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003; 41: 1561–1567.[Abstract/Free Full Text]

2. Gerber BL, Belge B, Legros GJ, Lim P, Poncelet A, Pasquet A, Gisellu G, Coche E, Vanoverschelde JLJ. Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation. 2006; 113: 823–833.[Abstract/Free Full Text]

3. Lardo AC, Cordeiro MAS, Silva C, Amado LC, George RT, Saliaris AP, Schuleri KH, Fernandes VR, Zviman M, Nazarian S, Halperin HR, Wu KC, M. Hare JM, Lima JAC. Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation. 2006; 113: 394–404.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Eur Heart JHome page
J.-B. le Polain de Waroux, A.-C. Pouleur, C. Goffinet, A. Pasquet, J.-L. Vanoverschelde, and B. L. Gerber
Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging
Eur. Heart J., October 2, 2008; 29(20): 2544 - 2551.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shiozaki, A. A.
Right arrow Articles by Rochitte, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shiozaki, A. A.
Right arrow Articles by Rochitte, C. E.
Related Collections
Right arrow Hypertrophy
Right arrow Myocardial cardiomyopathy disease
Right arrow CT and MRI